Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications

H Zhang, K Yang, F Chen, Q Liu, J Ni, W Cao… - Frontiers in …, 2022 - frontiersin.org
The CCL2-CCR2 axis is one of the major chemokine signaling pathways that has received
special attention because of its function in the development and progression of …

CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease

TT Chang, C Chen, JW Chen - Cardiovascular Diabetology, 2022 - Springer
Chemokines are key components in the pathology of chronic diseases. Chemokine CC motif
ligand 7 (CCL7) is believed to be associated with cardiovascular disease, diabetes mellitus …

Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

TT Chang, JW Chen - Cardiovascular diabetology, 2016 - Springer
Chemokines are critical components in pathology. The roles of chemokine CC motif ligand 4
(CCL4) and its receptor are associated with diabetes mellitus (DM) and atherosclerosis …

Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

Q Zhao - Journal of leukocyte biology, 2010 - academic.oup.com
This review presents evidence that dual targeting of CCR2 and CCR5 has greater
therapeutic potential than targeting either receptor alone. A cardinal feature of inflammation …

[HTML][HTML] The CCL5/CCR5 axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching

CS Lin, PS Hsieh, LL Hwang, YH Lee… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Hyperlipidemia induces dysfunction in the smooth muscle cells (SMCs) of
the blood vessels, and the vascular remodeling that ensues is a key proatherogenic factor …

Targeting the CCL2–CCR2 axis for atheroprotection

MK Georgakis, J Bernhagen, LH Heitman… - European heart …, 2022 - academic.oup.com
Decades of research have established atherosclerosis as an inflammatory disease. Only
recently though, clinical trials provided proof-of-concept evidence for the efficacy of anti …

[HTML][HTML] CCL5/CCR5 axis in human diseases and related treatments

Z Zeng, T Lan, Y Wei, X Wei - Genes & diseases, 2022 - Elsevier
To defense harmful stimuli or maintain the immune homeostasis, the body produces and
recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among …

CCL2-CCR2 signaling in disease pathogenesis

T O'Connor, L Borsig… - Endocrine, Metabolic & …, 2015 - ingentaconnect.com
The role of chemokines and their receptors in controlling several physiological and
pathological processes has only become evident in the last couple of years. From a sole …

Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease

CN França, MCO Izar, MNS Hortêncio… - Clinical …, 2017 - portlandpress.com
Monocytes circulate in the blood and migrate to inflammatory tissues, but their functions can
be either detrimental or beneficial, depending on their phenotypes. In humans, classical …

Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases

R Altara, M Manca, RD Brandão, A Zeidan… - Clinical …, 2016 - portlandpress.com
The CXC chemokines, CXCL4,-9,-10,-11, CXCL4L1, and the CC chemokine CCL21,
activate CXC chemokine receptor 3 (CXCR3), a cell-surface G protein-coupled receptor …